Abiopharma

BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA

Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook

Spyre Therapeutics Announces Grants of Inducement Awards

WAGNER CHARLES F JR 🟡 adjusted position in 9.5K shares (1 derivative) of VERTEX PHARMACEUTICALS INC / MA (VRTX) at $461.00 ($8.0M) Transaction Date: Jan 06, 2026 | Filing ID: 000002

Schmid John P. 🟢 acquired 9.5K shares (2 derivative) of ANAPTYSBIO, INC (ANAB) at $43.91 Transaction Date: Jan 06, 2026 | Filing ID: 000001

New Form SCHEDULE 13G/A - PLIANT THERAPEUTICS, INC. Filed: 2026-01-08 AccNo: 0000895421-26-000001 Size: 8 KB

New Form S-8 - LISATA THERAPEUTICS, INC. Filed: 2026-01-08 AccNo: 0000320017-26-000003 Size: 108 KB

Issa Mohamed Khairie 🔴 sold 19.1K shares of INCYTE CORP (INCY) at $109.07 ($2.1M) Transaction Date: Jan 06, 2026 | Filing ID: 000002

New Form S-3 - Flora Growth Corp. Filed: 2026-01-08 AccNo: 0001062993-26-000127 Size: 494 KB

(99% Neutral) PHATHOM PHARMACEUTICALS, INC. (PHAT) Announces Business Combination

Director Bassler Bonnie L 🟡 adjusted position in 1.5K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $800.00 ($2.3M) Transaction Date: Jan 07, 2026 | Filing ID: 000008

Ware J. Anthony 🟢 acquired 9.5K shares (2 derivative) of ANAPTYSBIO, INC (ANAB) at $43.91 Transaction Date: Jan 06, 2026 | Filing ID: 000001

(90% Positive) PACIRA BIOSCIENCES, INC. (PCRX) Provides Update on leader for sustainable

Orwin John A 🟢 acquired 14.2K shares (2 derivative) of ANAPTYSBIO, INC (ANAB) at $43.91 Transaction Date: Jan 06, 2026 | Filing ID: 000001